Physician profile
Charles Abavare
NPI 1790081156
$453.91
in general payments reported to CMS, 2019-2025
13 companies · $86.67 in 2025
The $86.67 reported for 2025 was less than what a typical Adult Medicine provider received nationally (typical 2025 total: $127).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $41.82 · 2021: $107 · 2022: $25.23 · 2023: $31.81 · 2024: $41.36 · 2025: $86.67.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $160.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $159.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbott Laboratories | $99.97 | 2024-2025 | Freestyle Libre 3 |
| Novo Nordisk INC | $87.47 | 2020-2022 | |
| Teva Pharmaceuticals USA, INC. | $70.56 | 2019 | |
| Amgen INC. | $40.87 | 2019-2021 | |
| Genentech USA, INC. | $32.91 | 2019-2021 | |
| Boston Scientific Corporation | $28.06 | 2025 | Watchman Flx |
| Boehringer Ingelheim Pharmaceuticals, INC. | $18.35 | 2023 | Ofev |
| Pfizer INC. | $13.69 | 2019 | |
| Lilly USA, LLC | $13.46 | 2023 | Mounjaro |
| Glaxosmithkline, LLC. | $12.84 | 2022 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $12.18 | 2019 | |
| Adlon Therapeutics L.P. | $12.15 | 2021 | |
| Abbvie INC. | $11.40 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Charles Abavare listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.